Do antihypertensive drugs precipitate diabetes in predisposed men?

British Medical Journal

Volumn 298, Issue 6681, 1989, Pages 1147-1152

  Skarfors, E T ^a   Lithell, H O ^a   Selinus, I ^a   Aberg, H ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDRALAZINE; THIAZIDE DIURETIC AGENT;

CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0024563429     PISSN: 02670623     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.298.6681.1147     Document Type: Article

References (16)

1. Bengtsson, C.; Blohme, G.; Lapidus, L. Do antihypertensive drugs precipitate diabetes? Br Med J 1984 10.1136/bmj.289.6457.1495 289 1495
2. Murphy, M.B.; Lewis, P.J.; Kohner, E.; Schumer, B.; Dollery, C.T. Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up Lancei 1982 ii: 1293
3. Ames, R.P.; Hill, P. Increase in serum-lipids during treatment of hypertension with chlorthalidone Lancet 1976 10.1016/S0140-6736(76)93093-2 i: 721
4. Tanaka, N.; Sakaguchi, S.; Oshige, K.; Niimura, T.; Kanehisa, T. Effect of chronic administration of propranolol on lipoprotein composition Metabolism 1976 10.1016/0026-0495(76)90014-7 25 1071
5. Waal-Manning, H.J.; Simpson, F.O. Beta-blockers and lipid metabolism 1977 ii: 705
6. Day, J.L.; Simpson, N.; Metcalfe, J.; Page, R.L. Metabolic consequences ofatenolol and propranolol in treatment of essential hypertension Br Medj 1979 i: 77
7. Lasser, N.L.; Grandits, G.; Caggiula, A.W. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the multiple risk factor intervention trial AmyMed 1984 76 52 2
8. Hedstrand, H. A study of middle-aged men with particular reference to risk factors for cardiovascular disease UpsJ7Med Sci 1975 19
9. Aberg, H.; Hedstrand, H.; Lithell, H. Blood pressure control in a middle-aged male population. A 6-9 year follow-up with special reference to the problem of non-responders Acta Med Scand 1980 208 467
10. Ikkos, D.; Luft, R. On the glucose tolerance test Acta Endocrinol 1957 25 31234
11. Burstein, M.; Samaille, J. Sur un dosage rapide de cholesterol lie au alphaet betalipoproteins du serum Clin Chim Acta 1955 10.1016/0009-8981(60)90075-9 5 609
12. Hulley, S.B.; Furberg, C.D.; Gurland, B. Systolic hypertension in the elderly program (SHEP): antihypertensive efficacy of chlorthalidone AmJI Cardiol 1985 10.1016/0002-9149(85)90404-7 56 913
13. Castelli, W.P. The triglyceride issue: a view from Framingham Am Heart J 1986 10.1016/0002-8703(86)90296-6 112 432
14. Aberg, H.; Lithell, H.; Selinus, I.; Hedstrand, H. Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10-year follow-up of Uppsala primary preventive study Atherosclerosis 1985 10.1016/0021-9150(85)90156-X 54 89
15. Pyoralti, K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland Diabetes Care 1979 10.2337/diacare.2.2.131 2 131
16. Welborn, T.A.; Wearne, K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations Diabetes Care 1979 10.2337/diacare.2.2.154 2 154